Enhanced Clinics for Patients Diagnosed With Ankylosing Spondylitis and Psoriatic Arthritis (ECAP)

N

NHS Lothian

Status

Unknown

Conditions

Spondylitis, Ankylosing
Psoriatic Arthritis

Study type

Observational

Funder types

Other

Identifiers

NCT04341233
IRAS No: 265399

Details and patient eligibility

About

The 19.5 months project will pilot the introduction of a hospital-based, nurse-led ankylosing spondylitis (AS) and psoriatic arthritis (PsA) service for patients being initiated on biologic therapy in NHS Lothian Edinburgh Western General Hospital. It is anticipated that this new model of care will improve: The time from referral for biologic therapy to initiation of treatment with a biological therapy due to the dedicated nurse to see patients The management and monitoring of AS and PsA patients post commencement of treatment , in line with The National Institute for Health and Care Excellence (NICE) guidelines

Enrollment

170 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Clinical diagnosis of AS or PsA
  • Referral for initiation of biological therapy by patients regular consultant
  • Age 18 years or older
  • Willing and able to give informed consent

Exclusion criteria

· Unable to comply with study procedures

Trial contacts and locations

0

Loading...

Central trial contact

Neil McKay, Dr; Barbara Kuske, Dr

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems